Bleicher Josh, Brooke Benjamin Sands, Bayless Kimberlee, Anderson Zachary, Beckstrom Julie, Zhang Chong, Presson Angela P, Huang Lyen C, Buys Michael Jacob
Surgery, University of Utah Health Hospitals and Clinics, Salt Lake City, Utah, USA.
Surgery, VA Salt Lake City Health Care System, Salt Lake City, Utah, USA.
Reg Anesth Pain Med. 2022 May 6. doi: 10.1136/rapm-2021-103382.
Understanding postoperative opioid use patterns among different populations is key to developing opioid stewardship programs.
We performed a retrospective cohort study on opioid prescribing, use, and pain after general surgery procedures for patients cared for by a transitional pain service at a veterans administration hospital. Discharge opioid prescription quantity, 90-day opioid prescription, and patient reported outcome pain measures were compared between chronic opioid users and non-opioid users (NOU). Additionally, 90-day total opioid use was evaluated for NOU.
Of 257 patients, 34 (13%) were on chronic opioid therapy, over 50% had a mental health disorder, and 29% had a history and/or presence of a substance use disorder. NOU were prescribed a median (IQR) of 10 (7, 12) tablets at discharge, while chronic opioid users were prescribed 6 (0, 12) tablets (p<0.001). 90-day opioid prescription (not including baseline opioid prescription for chronic users) was 10 (7, 15) and 6 (0, 12) tablets, respectively (p=0.001). There were no differences in changes in pain intensity or pain interference scores during recovery between groups. Median 90-day opioid use post discharge for NOU was 4 (0, 10) pills.
Non-opioid and chronic opioid users required very few opioid pills following surgery, and patients on chronic opioid therapy quickly returned to their baseline opioid use after a small opioid prescription at discharge. There was no difference in pain recovery between groups. Opioid prescribing guidelines should include patients on chronic opioid therapy and could consider recommending a more conservative prescribing approach.
了解不同人群术后阿片类药物的使用模式是制定阿片类药物管理计划的关键。
我们对一家退伍军人管理医院的过渡性疼痛服务所护理的患者进行了一项关于普通外科手术后阿片类药物处方、使用和疼痛的回顾性队列研究。比较了慢性阿片类药物使用者和非阿片类药物使用者(NOU)的出院阿片类药物处方量、90天阿片类药物处方以及患者报告的结局疼痛指标。此外,还评估了NOU的90天阿片类药物总使用量。
在257名患者中,34名(13%)接受慢性阿片类药物治疗,超过50%患有精神疾病,29%有物质使用障碍病史和/或存在物质使用障碍。NOU出院时的阿片类药物处方中位数(IQR)为10(7,12)片,而慢性阿片类药物使用者的处方量为6(0,12)片(p<0.001)。90天阿片类药物处方(不包括慢性使用者的基线阿片类药物处方)分别为10(7,15)片和6(0,12)片(p=0.001)。两组之间恢复期间的疼痛强度变化或疼痛干扰评分没有差异。NOU出院后90天阿片类药物使用中位数为4(0,10)片。
非阿片类药物使用者和慢性阿片类药物使用者术后所需的阿片类药物很少,慢性阿片类药物治疗患者在出院时开具少量阿片类药物处方后很快恢复到基线阿片类药物使用量。两组之间的疼痛恢复没有差异。阿片类药物处方指南应包括接受慢性阿片类药物治疗的患者,并可考虑推荐更保守的处方方法。